首页> 外文期刊>Lasers in surgery and medicine >Pulsed dye laser and intralesional bleomycin for treatment of resistant viol hand warts.
【24h】

Pulsed dye laser and intralesional bleomycin for treatment of resistant viol hand warts.

机译:脉冲染料激光器和intralesional博来霉素治疗耐药开口手疣。

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Objective Viral warts affect 7--10% ofthe population and are a major burden on time and resources of dermatology departments everywhere. Some warts prove resistant to multiple therapies, and this is particularly common in the immunosuppressed patient. Numerous treatments are available, but no one treatment has emerged as the treatment of choice. Bleomycin has been shown to be effective in treating warts, but administration can be difficult with risk of local complications. To demonstrate a new technique for easily and safely administrating bleomycin into warts, we undertook an open study to assess the practicality, efficacy, and tolerability of pulsed dye laser immediately followed by intralesional bleomycin in resistant viral hand warts. Study Design/Materials and Methods Ten subjects, all with resistant viral hand warts of at least 3 years duration were recruited. Four subjects were on long-term immunosuppressant drugs. Eighteen warts treated in total. Area of the wart was anaesthetized with 1% lignocaine, then treated with a pulsed dye laser (7 mm spot, fluence 10 J/cm(2)). Immediately following this bleomycin (0.5 IU/ml) was injected into the base of the wart. Monthly follow-up and treatment until satisfactory clearance. RESULTS: Sixteen out of eighteen warts cleared (89%). Eight out of ten warts in the immunosuppressed subjects cleared. The remaining two warts responded partially to two treatments, but the patient was happy with the result and did not wish further treatment. All warts in the immunocompetent subjects cleared. No serious side effects were seen. CONCLUSIONS: The initial treatment of the wart with pulsed dye laser serves to "prepare" the wart for the bleomycin injection, which can then be given very easily. This ensures the drug is deposited into the base of the wart where it is most needed and minimises the risk of infiltration of normal skin or the operative environment. This method of combining pulsed dye laser and intralesional bleomycin appears to be a safe, rapid, well tolerated, and successful treatment for resistant hand warts. It has proven to be effective in warts in immunosuppressed patients and at difficult sites (e.g., subungual warts). These findings need confirmation from a larger controlled study.
机译:背景和目的病毒疣影响7 - 10%人口和时间是一个主要的负担皮肤科和资源部门无处不在。多种治疗方法,这是特别常见的免疫抑制病人。治疗可用,但没有人治疗已成为治疗的首选。已被证明是有效的治疗尖锐湿疣,但政府可以困难的风险当地的并发症。技术很容易和安全管理博来霉素为疣,我们进行了一个开放的研究评估的实用性、有效性和立即耐受性的脉冲染料激光器其次是intralesional博来霉素耐药病毒疣。方法十个主题,所有与耐药病毒手疣至少3年的时间招募。免疫抑制药物。在总。1%利多卡因,然后处理脉冲染料激光(7毫米,影响10 J /厘米(2))。紧跟着这博来霉素(0.5国际单位/毫升)被注入的疣。随访和治疗,直到满意间隙。清除(89%)。免疫抑制对象清除。两个疣回应部分两个治疗,但是,病人满意结果不希望进一步治疗。免疫活性的研究对象清除。效果观察。与脉冲染料激光治疗疣是“准备”博来霉素的疣注入,然后可以很容易。这样可以确保药物存入基础最需要的疣和最小化正常皮肤的渗透或的风险手术环境。脉冲染料激光器和intralesional博来霉素似乎是一个安全、快速、耐受性良好,成功治疗耐药的手疣。已经被证明是有效的在疣吗免疫抑制患者和困难的地点(例如,指甲下的疣)。确认从一个更大的对照研究。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号